Five Prime
Five Prime is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of gastric cancer.
Business Model:
Revenue: $13.2M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Five Prime Information
Five Prime was acquired by
Amgen.
The acquisition happend on 2021-03-04.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 111 Oyster Point Boulevard
City: South San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$21M
Raised Total:$155M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Five Prime is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of gastric cancer.
Contact Phone:
+14153655600
Contact Email:
Five Prime went public on 9/18/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/18/2013
IPO Valuation:
$208M
Ticker Symbol:
FPRX
IPO Price:
$13/share
Amount Raised:
$62M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2005 | Series C | 10 | $45M |
Kleiner Perkins J.P. Morgan Securities Inc. Domain Associates Diamond Capital Company Wellcome Trust Singapore Bio-Innovations Advanced Technology Ventures HealthCap TPG Versant Ventures Kleiner Perkins J.P. Morgan Securities Inc. Domain Associates Diamond Capital Company Wellcome Trust Singapore Bio-Innovations Advanced Technology Ventures |
9/2013 | Post-IPO Equity | $62M | 5/2008 | Equity | $40.3M |
Advanced Technology Ventures Domain Associates Kleiner Perkins Caufield & Byers Healthcap Venture Capital Versant Ventures |
8/2010 | Equity | $7.5M | 5/2008 | Venture Round | 1 | - |
Pfizer Venture Investments Pfizer Venture Investments |
4/2012 | Private Equity Round | 2 | $10M |
Kleiner Perkins Versant Ventures Kleiner Perkins Versant Ventures |
12/2003 | Venture Round | $9.5M | 9/2013 | IPO | $62.4M |
|
3/2014 | Post-IPO Equity | $21M | 9/2010 | Venture Round | $7.5M | 5/2008 | Venture Round | 1 | - |
Pfizer Venture Investments Pfizer Venture Investments |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
